Nevada Administrative Code (Last Updated: January 6, 2015) |
Chapter441A Infectious Diseases; Toxic Agents |
INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES |
Miscellaneous Communicable Diseases |
NAC441A.565. Hepatitis A: Presence of case in child care facility.
-
1. If a case having hepatitis A is an employee or a child in a child care facility and there are no children in diapers in the child care facility, the health authority shall offer appropriate prophylaxis to all employees and children in contact with the case and who have not been vaccinated against hepatitis A.
2. The health authority shall offer appropriate prophylaxis to all employees and enrolled children in a child care facility who have not been vaccinated against hepatitis A if a child in diapers is enrolled in the child care facility and:
(a) A case having hepatitis A is an employee or a child in the child care facility; or
(b) A case having hepatitis A has occurred in the households of two or more children in the child care facility.
3. If recognition of an outbreak of hepatitis A is delayed by 3 or more weeks from the onset of the index case, or if hepatitis A has occurred in three or more families of children enrolled in a child care facility, the health authority shall offer appropriate prophylaxis to all employees and enrolled children in the child care facility who have not been vaccinated against hepatitis A and to contacts who have not been vaccinated against hepatitis A residing in the same household as a child 3 years of age, or less, who is enrolled in the child care facility.
4. If a case having hepatitis A is an employee or a child in a child care facility, the principal, director or other person in charge of the child care facility shall notify, in writing, the employees of the child care facility and the parents or legal guardians of children enrolled in the child care facility of the potential exposure of the children enrolled in the child care facility to hepatitis A, of the recommendations for prophylaxis and of the need for surveillance for development of symptoms.
(Added to NAC by Bd. of Health, eff. 1-24-92; A by R087-08, 1-13-2011)